FAN Xia. Influence of diltiazem intravenous infusion on the cardiac function of patients with cardiovascular disease[J]. Journal of Clinical Medicine in Practice, 2014, (13): 13-15,19. DOI: 10.7619/jcmp.201413005
Citation: FAN Xia. Influence of diltiazem intravenous infusion on the cardiac function of patients with cardiovascular disease[J]. Journal of Clinical Medicine in Practice, 2014, (13): 13-15,19. DOI: 10.7619/jcmp.201413005

Influence of diltiazem intravenous infusion on the cardiac function of patients with cardiovascular disease

More Information
  • Published Date: September 10, 2014
  • Objective To analyze the impact of diltiazem intravenous infusion on the cardiac function of patients with cardiovascular disease.Methods Clinical materials of patients with cardio-vascular disease were retrospectively analyzed,and they were divided into group A (dilated car-diomyopathy),group B (coronary heart disease)and group C (hypertensive disease)according to the treatment.The levels of SBP,HR,IVSd,LVED,LVPWd,DT and BNP were analyzed and compared among three groups.Results A total of 60 patients were retrospective analyzed,includ-ing 20 in each group.The levels of LVPWd and DT in group A before the treatment were signifi-cantly higher than that after the treatment.The level of BNP in group A before the treatment was significantly lower than that after the treatment.The levels of SBP,HR,BNP and DT in group B before the treatment were significantly lower than that after the treatment.The levels of SBP,BNP and DT in group C before the treatment were significantly lower than that after the treatment.Con-clusion For the patients with dilated cardiomyopathy,coronary heart disease or hypertension, continuous intravenous infusion with diltiazem can reduce blood pressure and heart rate,and im-prove the status of myocardial ischemia and cardiac diastolic function.
  • Adibkia K, Shokri J, Barzegar-Jalali M. Effect of sol-vent type on retardation properties of diltiazem HCl form liqu-isolid tablets [J]. Colloids and Surfaces B-Biointerfaces, 2014.10.
    Campbell M, Ahluwalia J, Watson AC. Diltiazem-associated hyperpigmentation [J]. Journal of General Internal Medicine, 2013, (12):1676.
    Shah M, Sandler L, Rai V. Quality of compounded topical 2% diltiazem hydrochloride formulations for anal fis-sure [J]. World Journal of Gastroenterology, 2013, (34):5645.
    Chen P, Deng Z, Wang T. The potential interaction of MARCKS-related peptide and diltiazem on acrolin-induced airway mucus hypersecretion in rats [J]. Int Immunopharma-col, 2013(3):625.
    Bologa C, Lionte C, Coman A. Lipid emulsion therapy in cardiodepressive syndrome after diltiazem overdose-case re-port [J]. American Journal of Emergency Medicine, 2013(7):1154.
    Shojaee S, Asare-Addo K, Kaialy W. An investigation into the stabilization of diltiazem HCl release from matrices made from aged polyox powders [J]. AAPS PHARMSCITECH, 2013(3):1190.
    Adibkia K, Ghanbarzadeh S, Shokri MH. Micro-porous surfaces in controlled drug delivery systems:design and evalu-ation of diltiazem hydrochloride controlled porosity osmotic pump using non-ionic surfactants as pore-former [J]. Pharmaceutical Development and Technology, 2014(4):507.
    Jindal T, Mandal S N, Biswas G. Evaluation of the ef-ficacy of a combination of diltiazem and periprostatic nerve block in pain control during transrectal ultrasonography-guided biopsy of the prostate [J]. Annals of the Royal College of Surgeons of England, 2013(5):361.
    Zheng T, Su C H, Zhao J. Effects of CYP3A5 and CYP2D6 genetic polymorphism on the pharmacokinetics of diltiazem and its metabolites in Chinese subjects [J]. PHARMAZIE, 2013(4):257.
    Qazi F, Shoaib MH, Yousuf R I. Formulation develop-ment and evaluation of Diltiazem HCl sustained release matrix tablets using HPMC K4Mand K100M [J]. Pak J Pharm Sci, 2013(4):653.
    Ma MK, Kwan L P, Mok M M. Significant reduction of Tacrolimus trough level after conversion from twice daily Prograf to once daily Advagraf in Chinese renal transplant re-cipients with or without concomitant diltiazem treatment [J]. Renal Failure, 2013(7):942.
    Bulus H, Varol N, Tas A. Comparison of topical isosorbide mononitrate, topical diltiazem, and their combina-tion in the treatment of chronic anal fissure [J]. Asian J Surg, 2013(4):165.
    Bai Y, Hu L, Wu J. Effects of intravenous diltiazem in a rat model of experimental coronary thrombotic microembo-lism [J]. Exp Ther Med, 2013(4):873.
  • Related Articles

    [1]SHI Qianqian, LIU Jingjing. Risk factor and construction of nomogram prediction model for pertussis in children[J]. Journal of Clinical Medicine in Practice, 2025, 29(6): 56-61. DOI: 10.7619/jcmp.20244333
    [2]PANG Ting, WU Weili, YANG Binjiao. Pathogen status, risk factors and prediction model construction for catheter-related infection in patients with maintenance hemodialysis[J]. Journal of Clinical Medicine in Practice, 2024, 28(21): 60-65. DOI: 10.7619/jcmp.20243000
    [3]LI Juanjuan, LIN Yan, WANG Weiping. Value of three-dimensional energy Doppler ultrasound parameters combined with placental growth factor in predicting early-onset fetal growth restriction[J]. Journal of Clinical Medicine in Practice, 2024, 28(10): 13-16, 23. DOI: 10.7619/jcmp.20234096
    [4]LIU Haijia, CHEN Ming, LI Yanzhen. Analysis in risk factors of postoperative recurrence of patients with refractory epilepsy and establishment of a risk prediction model[J]. Journal of Clinical Medicine in Practice, 2024, 28(8): 7-11. DOI: 10.7619/jcmp.20240080
    [5]LIU Chen, YE Jianwen, WANG Xuemei, LI Hua. Predictive value of serum microRNA-506 and microRNA-934 levels in postoperative survival outcome of patients with pancreatic cancer[J]. Journal of Clinical Medicine in Practice, 2024, 28(5): 40-43. DOI: 10.7619/jcmp.20233000
    [6]DING Tianjia, SUN Tao, WU Mingfeng, YIN Haibing. Risk factors of electrocardiogram abnormalities in patients with primary liver cancer and its value in predicting prognosis[J]. Journal of Clinical Medicine in Practice, 2024, 28(3): 100-104. DOI: 10.7619/jcmp.20233012
    [7]YOU Danye, SHI Jiaping. Comparison of predictive value of cervical length measured by two transvaginal ultrasonography methods for preterm birth in early stage of second trimester[J]. Journal of Clinical Medicine in Practice, 2023, 27(18): 138-141. DOI: 10.7619/jcmp.20231486
    [8]ZHOU Lanmei, JIANG Lijun, ZHU Fengxia, ZHAO Xuemei, JIN Yanting. Analysis in risk factors of respiratory tract infectionin preschool children and construction of nomogram prediction model[J]. Journal of Clinical Medicine in Practice, 2021, 25(14): 9-14. DOI: 10.7619/jcmp.20211520
    [9]CAO Dalong, WANG Changhai. Value of red cell distribution width in predicting the severity and prognosis of community acquired pneumonia[J]. Journal of Clinical Medicine in Practice, 2021, 25(1): 85-87. DOI: 10.7619/jcmp.20200415
    [10]CAO Lan, TAO Yujian, ZHAO Yuanlu, ZHANG Pan. Analysis in risk factors of solitary pulmonary nodules[J]. Journal of Clinical Medicine in Practice, 2021, 25(1): 38-40, 44. DOI: 10.7619/jcmp.20200457
  • Cited by

    Periodical cited type(7)

    1. 赵晓亮,孙梅兰,闫天元,张世喆,牛国昌,关玉龙,李华. 拇外翻畸形截骨矫形后第一跖骨三维层面畸形指标的量化分析. 中国组织工程研究. 2024(33): 5302-5307 .
    2. 张耀天,崔军,居嘉忆,梁峻箫,孙微. 3D打印辅助第3代微创Chevron截骨术治疗轻中度■外翻的临床疗效. 中国临床医生杂志. 2024(03): 333-335 .
    3. 马昌志,田文平,高晗,由夫超,何雪峰,王巍. 应用抗生素骨水泥植入技术治疗第一跖趾关节痛风石并骨缺损的短期疗效研究. 骨科. 2024(02): 133-139 .
    4. 曹旭含,熊冰朗,孙承颐,孙旭东,郭紫嫣,温建民,孙卫东. 步态周期中“8”字绷带外固定对微创治疗拇外翻术后截骨端动态稳定性的有限元分析. 中国医疗设备. 2024(08): 11-19 .
    5. 温冠楠,程桯,蒋科卫,豆以彪,奚向宇,白志强,温建民. 温建民微创(足母)外翻病症诊疗体系学术思想及运用. 广州中医药大学学报. 2024(10): 2568-2575 .
    6. 邰耀,成永忠,陈奕历,李润民,陈雨欣,程大鹏,王文,温建民,蒋科卫. 拇外翻微创截骨术后“8”字绷带固定对截骨端背侧移位影响的尸体研究. 中医药导报. 2023(08): 71-75 .
    7. 李帅,郝光亮. 桃红接骨胶囊联合微创截骨手法整复术治疗拇外翻临床观察. 亚太传统医药. 2023(12): 107-110 .

    Other cited types(0)

Catalog

    Article views (197) PDF downloads (0) Cited by(7)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return